Market overview
The global hospital-at-home vital signs monitoring platforms market is worth USD 614 mn in 2026 and is forecast to reach USD 2.5 bn by 2036, growing at a 15.0% CAGR. United States is the largest country market and Wearables and monitoring devices is the largest by component segment.
| Scope | Platforms that monitor acutely ill patients treated at home: wearable sensors, connected vital-sign kits, software dashboards and clinical integration services for hospital-at-home programmes. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 520 mn |
| Value 2026 | USD 614 mn |
| Value 2036 | USD 2.5 bn |
| CAGR 2026-2036 | 15.0% |
| Volume 2026 | 1,788 thousand patient episodes |
| Volume 2036 | 7,998 thousand patient episodes |
| Average price 2026 | USD 343 per patient episode |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Hospital-at-Home Vital Signs Monitoring Platforms market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 614 mn |
| 2027 | USD 706 mn |
| 2028 | USD 811 mn |
| 2029 | USD 933 mn |
| 2030 | USD 1.1 bn |
| 2031 | USD 1.2 bn |
| 2032 | USD 1.4 bn |
| 2033 | USD 1.6 bn |
| 2034 | USD 1.9 bn |
| 2035 | USD 2.2 bn |
| 2036 | USD 2.5 bn |
Hospital-at-Home Vital Signs Monitoring Platforms market segmentation
By component
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Wearables and monitoring devices | 40.0% | 34.1% | USD 245 mn | 13.2% |
| Software platforms | 36.0% | 43.5% | USD 221 mn | 17.2% |
| Services and integration | 24.0% | 22.4% | USD 147 mn | 14.2% |
By care type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Acute care substitution | 56.0% | 59.5% | USD 344 mn | 15.7% |
| Post-acute recovery | 30.0% | 26.8% | USD 184 mn | 13.7% |
| Oncology and infusion at home | 14.0% | 13.7% | USD 86 mn | 14.7% |
By vital sign
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Heart rate and electrocardiogram | 28.0% | 27.0% | USD 172 mn | 14.6% |
| Blood pressure | 22.0% | 20.0% | USD 135 mn | 13.9% |
| Oxygen saturation and respiration | 26.0% | 26.0% | USD 160 mn | 15.0% |
| Temperature, glucose and other | 24.0% | 27.0% | USD 147 mn | 16.4% |
By wearability
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Patch type | 36.0% | 38.0% | USD 221 mn | 15.6% |
| Wrist-worn | 28.0% | 28.0% | USD 172 mn | 15.0% |
| Contact-based peripherals | 36.0% | 34.0% | USD 221 mn | 14.3% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Health systems | 60.0% | 56.0% | USD 368 mn | 14.2% |
| Payers | 18.0% | 20.0% | USD 110 mn | 16.2% |
| Independent providers | 22.0% | 24.0% | USD 135 mn | 16.0% |
Top 25 countries for hospital-at-home vital signs monitoring platforms by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 94.0% of 2026 revenue and the 25 countries below together hold 98.4%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 393 mn | 64.0% | USD 1.6 bn | 15.2% |
| 2 | United Kingdom | USD 37 mn | 6.0% | USD 144 mn | 14.6% |
| 3 | Australia | USD 25 mn | 4.0% | USD 102 mn | 15.3% |
| 4 | Germany | USD 25 mn | 4.0% | USD 92 mn | 14.1% |
| 5 | Spain | USD 18 mn | 3.0% | USD 70 mn | 14.2% |
| 6 | Israel | USD 18 mn | 3.0% | USD 74 mn | 15.0% |
| 7 | Canada | USD 18 mn | 3.0% | USD 72 mn | 14.6% |
| 8 | Japan | USD 18 mn | 3.0% | USD 67 mn | 13.8% |
| 9 | France | USD 12 mn | 2.0% | USD 47 mn | 14.4% |
| 10 | Singapore | USD 12 mn | 2.0% | USD 52 mn | 15.6% |
| 11 | Italy | USD 2.6 mn | 0.4% | USD 9.7 mn | 13.9% |
| 12 | Netherlands | USD 2.3 mn | 0.4% | USD 8.4 mn | 14.0% |
| 13 | China | USD 2.3 mn | 0.4% | USD 13 mn | 18.8% |
| 14 | South Korea | USD 2.3 mn | 0.4% | USD 8.4 mn | 14.0% |
| 15 | Brazil | USD 1.9 mn | 0.3% | USD 8.7 mn | 16.4% |
| 16 | Switzerland | USD 1.9 mn | 0.3% | USD 7.0 mn | 13.8% |
| 17 | Sweden | USD 1.9 mn | 0.3% | USD 7.0 mn | 13.8% |
| 18 | India | USD 1.5 mn | 0.2% | USD 8.4 mn | 18.6% |
| 19 | Saudi Arabia | USD 1.5 mn | 0.2% | USD 7.0 mn | 16.3% |
| 20 | United Arab Emirates | USD 1.5 mn | 0.2% | USD 7.0 mn | 16.3% |
| 21 | Belgium | USD 1.5 mn | 0.2% | USD 5.7 mn | 14.1% |
| 22 | Denmark | USD 1.5 mn | 0.2% | USD 5.7 mn | 14.1% |
| 23 | Ireland | USD 1.5 mn | 0.2% | USD 5.7 mn | 14.1% |
| 24 | Norway | USD 1.2 mn | 0.2% | USD 4.2 mn | 13.7% |
| 25 | Mexico | USD 1.2 mn | 0.2% | USD 5.2 mn | 16.2% |
| Rest of world | USD 10 mn | 1.6% | USD 41 mn | 14.9% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Philips
- Masimo
- GE HealthCare
- Medtronic
- Baxter
- Omron Healthcare
Group 2: Regional and specialist players
- BioIntelliSense
- Vivalink
- Current Health
- DispatchHealth
- Biofourmis
- Health Recovery Solutions
- Withings
- Sensium
Group 3: Emerging and niche players
- Inbound Health
- Biobeat
- Doccla
- Vitls
- Sibel Health
- Spry Health
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the hospital-at-home vital signs monitoring platforms market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 15.0% is calculated from the resulting values.
The market is divided by component, by care type, by vital sign, by wearability, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the hospital-at-home vital signs monitoring platforms market?
The global hospital-at-home vital signs monitoring platforms market is estimated at USD 520 mn in 2025 and USD 614 mn in 2026.
How fast will the hospital-at-home vital signs monitoring platforms market grow?
It is forecast to reach USD 2.5 bn by 2036, a compound annual growth rate of 15.0% from 2026, an increase of USD 1.9 bn.
Which country is the largest market for hospital-at-home vital signs monitoring platforms?
United States is the largest market by revenue at USD 393 mn in 2026, 64.0% of the global total. The three largest countries together hold 74.0%.
Which country is growing fastest?
Among the ten largest markets, Singapore is growing fastest at 15.6% a year from 2026 to 2036.
Which hospital-at-home vital signs monitoring platforms segment is largest?
In the by component split, Wearables and monitoring devices is the largest segment with 40.0% of 2026 revenue.
Who are the leading hospital-at-home vital signs monitoring platforms companies?
Global leaders include Philips, Masimo, GE HealthCare, Medtronic.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Transplant Biomarker Risk StratificationUSD 616 mn · 8.5% CAGR
- High-end CellomicsUSD 610 mn · 7.0% CAGR
- Hospital-at-Home Monitoring PlatformsUSD 608 mn · 15.0% CAGR
- Neuromodulation Closed-Loop Brain-Computer InterfacesUSD 598 mn · 14.0% CAGR
- Clinic-Based Rehab Therapy RobotsUSD 632 mn · 9.5% CAGR
- Dystrophic Epidermolysis Bullosa ManagementUSD 632 mn · 8.0% CAGR
- Patient-Matched Orthopedic GuidesUSD 642 mn · 6.8% CAGR
- Handheld Point-of-Care UltrasoundUSD 660 mn · 9.5% CAGR
← Hospital-at-Home Monitoring Platforms Immunoadsorption Columns →